Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Receivables - Other (2019 - 2024)

Historic Receivables - Other for IM Cannabis (IMCC) over the last 5 years, with Q4 2024 value amounting to $197574.4.

  • IM Cannabis' Receivables - Other fell 7141.57% to $197574.4 in Q4 2024 from the same period last year, while for Dec 2024 it was $197574.4, marking a year-over-year decrease of 7141.57%. This contributed to the annual value of $201590.3 for FY2024, which is 7109.56% down from last year.
  • IM Cannabis' Receivables - Other amounted to $197574.4 in Q4 2024, which was down 7141.57% from $3.0 million recorded in Q3 2024.
  • IM Cannabis' 5-year Receivables - Other high stood at $11.5 million for Q2 2021, and its period low was $81307.8 during Q4 2020.
  • Its 5-year average for Receivables - Other is $4.1 million, with a median of $2.7 million in 2024.
  • As far as peak fluctuations go, IM Cannabis' Receivables - Other surged by 1403037.32% in 2021, and later plummeted by 9874.96% in 2022.
  • Quarter analysis of 5 years shows IM Cannabis' Receivables - Other stood at $81307.8 in 2020, then skyrocketed by 14030.37% to $11.5 million in 2021, then tumbled by 98.75% to $143657.1 in 2022, then surged by 381.14% to $691197.9 in 2023, then tumbled by 71.42% to $197574.4 in 2024.
  • Its Receivables - Other stands at $197574.4 for Q4 2024, versus $3.0 million for Q3 2024 and $2.7 million for Q2 2024.